3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
37
Neoplasms
3
Neoplasm Metastasis
3
Breast Diseases
3
Neoplasms by Site
2
Triple Negative Breast Neoplasms
1
Skin Diseases
1
Endometrial Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Lobular
1
Carcinoma, Intraductal, Noninfiltrating
1
Carcinoma, Ductal, Breast
1
Breast Neoplasms, Male
1
Breast Neoplasm Female
1
Breast Cancer Female
1
Advanced Breast Carcinoma
1
Interventions
palbociclib
1
Gonadotropin-Releasing Hormone
1
Anastrozole
1
AZD9833
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Skin Diseases
×
Anastrozole
×
Clear all
NCT04711252
2025-10-14
SERENA-4
AstraZeneca
Phase 3
Active not recruiting
1,370 enrolled